Literature DB >> 33336286

Liver-lung interactions in acute respiratory distress syndrome.

Raquel Herrero1,2,3, Gema Sánchez4,5, Iris Asensio6,7, Eva López4, Antonio Ferruelo8, Javier Vaquero6,7, Laura Moreno8,9, Alba de Lorenzo4, Rafael Bañares6,7, José A Lorente10,8,4,11.   

Abstract

Patients with liver diseases are at high risk for the development of acute respiratory distress syndrome (ARDS). The liver is an important organ that regulates a complex network of mediators and modulates organ interactions during inflammatory disorders. Liver function is increasingly recognized as a critical determinant of the pathogenesis and resolution of ARDS, significantly influencing the prognosis of these patients. The liver plays a central role in the synthesis of proteins, metabolism of toxins and drugs, and in the modulation of immunity and host defense. However, the tools for assessing liver function are limited in the clinical setting, and patients with liver diseases are frequently excluded from clinical studies of ARDS. Therefore, the mechanisms by which the liver participates in the pathogenesis of acute lung injury are not totally understood. Several functions of the liver, including endotoxin and bacterial clearance, release and clearance of pro-inflammatory cytokines and eicosanoids, and synthesis of acute-phase proteins can modulate lung injury in the setting of sepsis and other severe inflammatory diseases. In this review, we summarized clinical and experimental support for the notion that the liver critically regulates systemic and pulmonary responses following inflammatory insults. Although promoting inflammation can be detrimental in the context of acute lung injury, the liver response to an inflammatory insult is also pro-defense and pro-survival. A better understanding of the liver-lung axis will provide valuable insights into new diagnostic targets and therapeutic strategies for clinical intervention in patients with or at risk for ARDS.

Entities:  

Keywords:  Acute respiratory distress syndrome; Acute-phase response; Critical illness; Immunomodulation; Liver dysfunction; Liver–lung interaction; Mechanisms

Year:  2020        PMID: 33336286     DOI: 10.1186/s40635-020-00337-9

Source DB:  PubMed          Journal:  Intensive Care Med Exp        ISSN: 2197-425X


  86 in total

1.  Host mechanisms which act to remove bacteria from the blood stream.

Authors:  D E ROGERS
Journal:  Bacteriol Rev       Date:  1960-03

2.  Resolution of the adult respiratory distress syndrome following colectomy and liver transplantation.

Authors:  M Ali; W J Wall
Journal:  Chest       Date:  1990-10       Impact factor: 9.410

3.  Resolution of adult respiratory distress syndrome after recovery from fulminant hepatic failure.

Authors:  H Khanlou; H Souto; M Lippmann; S Muñoz; K Rothstein; Z Ozden
Journal:  Am J Med Sci       Date:  1999-02       Impact factor: 2.378

4.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.

Authors:  Giacomo Bellani; John G Laffey; Tài Pham; Eddy Fan; Laurent Brochard; Andres Esteban; Luciano Gattinoni; Frank van Haren; Anders Larsson; Daniel F McAuley; Marco Ranieri; Gordon Rubenfeld; B Taylor Thompson; Hermann Wrigge; Arthur S Slutsky; Antonio Pesenti
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

Review 5.  The acute respiratory distress syndrome.

Authors:  Michael A Matthay; Lorraine B Ware; Guy A Zimmerman
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

Review 6.  Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defense.

Authors:  G M Matuschak; J E Rinaldo
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

Review 7.  The acute respiratory distress syndrome: pathogenesis and treatment.

Authors:  Michael A Matthay; Rachel L Zemans
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

8.  Adult respiratory distress syndrome secondary to end-stage liver disease-successful outcome following liver transplantation.

Authors:  H R Doyle; I R Marino; A Miro; V Scott; M Martin; J Fung; D Kramer; T E Starzl
Journal:  Transplantation       Date:  1993-02       Impact factor: 4.939

9.  Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature.

Authors:  Elzbieta Kolaczkowska; Craig N Jenne; Bas G J Surewaard; Ajitha Thanabalasuriar; Woo-Yong Lee; Maria-Jesus Sanz; Kerri Mowen; Ghislain Opdenakker; Paul Kubes
Journal:  Nat Commun       Date:  2015-03-26       Impact factor: 14.919

Review 10.  Liver Macrophages: Old Dogmas and New Insights.

Authors:  Adrien Guillot; Frank Tacke
Journal:  Hepatol Commun       Date:  2019-04-22
View more
  3 in total

Review 1.  Alcoholic liver disease: a new insight into the pathogenesis of liver disease.

Authors:  Seol Hee Park; Young-Sun Lee; Jaemin Sim; Seonkyung Seo; Wonhyo Seo
Journal:  Arch Pharm Res       Date:  2022-06-27       Impact factor: 6.010

2.  Obesity Reshapes the Microbial Population Structure along the Gut-Liver-Lung Axis in Mice.

Authors:  Apostolos Galaris; Dionysios Fanidis; Elli-Anna Stylianaki; Vaggelis Harokopos; Alexandra-Styliani Kalantzi; Panagiotis Moulos; Antigone S Dimas; Pantelis Hatzis; Vassilis Aidinis
Journal:  Biomedicines       Date:  2022-02-19

Review 3.  The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation.

Authors:  Dustin Beyer; Jessica Hoff; Oliver Sommerfeld; Alexander Zipprich; Nikolaus Gaßler; Adrian T Press
Journal:  Mol Med       Date:  2022-07-30       Impact factor: 6.376

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.